The Wall Street Journal | Ed Silverman
Despite
the uncertainty facing the Greek economy, the leading pharmaceutical industry
trade group in Europe maintains that shipments of medicines will continue. At
the same time, the group is pressing the European Commission to take steps to
ensure that prices and supplies are not disrupted if Greece introduces its own
currency.
In
response to questions, a spokesman for the European Federation of
Pharmaceutical Industries and Associations says supplies are continuing and
that “we have discussed no limit, at present.” Drug makers are owed about $1.2
billion by hospitals and other payers, he says, adding that talks about
supplies are expected to be held this evening, given the fast-changing nature
of the Greek economic crisis.